New triple therapy aims to shrink Hard-to-Treat endometrial tumors
Disease control
Recruiting now
This early-phase study tests whether combining two cancer drugs (lenvatinib and pembrolizumab) with a short course of pelvic radiation is safe and effective for people with recurrent or inoperable endometrial cancer. About 18 participants will receive the treatment to find the be…
Phase: PHASE1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated May 22, 2026 14:03 UTC